...
首页> 外文期刊>Respirology Case Reports >Carcinomatous pleuritis and pericarditis accompanied by pulmonary tuberculosis
【24h】

Carcinomatous pleuritis and pericarditis accompanied by pulmonary tuberculosis

机译:癌性胸膜炎和心包炎伴有肺结核

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract Although both lung cancer and pulmonary tuberculosis (TB) commonly occur in clinical practice, little attention has been paid to their coexistence. A 62-year-old female was admitted with acute dyspnoea secondary to cardiac tamponade. During her admission, a mass lesion harbouring air bronchograms in the right upper lobe rapidly increased in size. Surgical lung, pericardial, and pleural specimens yielded TB from a nodule in the right upper lobe and lung adenocarcinoma from the pericardium and pleura. Anti-tuberculous therapy was administered and gefitinib was subsequently started after the positive identification of epidermal growth factor receptor (EGFR) mutation (exon 19 deletion). The patient's general condition gradually improved with the anti-tuberculous and the EGFR-tyrosine kinase inhibitor (EGFR-TKI) treatment. Dual pathology is important to consider in patients with atypical radiological appearances. In those with proven EGFR mutation positive for lung cancer and pulmonary TB, sequential anti-tuberculous medication followed by EGFR-TKI treatment is advised.
机译:摘要尽管肺癌和肺结核(TB)在临床实践中都普遍存在,但对其并存的关注却很少。一名62岁的女性因心脏压塞继发急性呼吸困难。在她入院期间,右上叶隐匿着气管造影的肿块病灶迅速增大。外科肺,心包和胸膜标本从右上叶的结节产生结核,而心包和胸膜则产生肺腺癌。在确定表皮生长因子受体(EGFR)突变(外显子19缺失)后,进行了抗结核治疗,随后开始了吉非替尼治疗。通过抗结核和EGFR-酪氨酸激酶抑制剂(EGFR-TKI)治疗,患者的总体状况逐渐得到改善。具有非典型影像学表现的患者应考虑双重病理学。对于那些已证明对肺癌和肺结核呈阳性EGFR突变的患者,建议先进行抗结核药物治疗,再进行EGFR-TKI治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号